≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_SKIN_EXALLC for full statistics.

Carcinoma in situ of skin

DOID EFO Endpoint Browser

CD2_INSITU_SKIN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_SKIN
489338

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D04
  • Cause of death: ICD-10 — D04
  • Cancer registry: Topography ICD-O-3 — C44
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

2809

4. Check minimum number of events

None

2809

5. Include endpoints

2819

6. Filter based on genotype QC (FinnGen only)

2819

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ cervicis uteri

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 2819 1475 1344
Unadjusted period prevalence (%) 0.55 0.50 0.59
Median age at first event (years) 74.12 73.66 74.64

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2396
Matched controls
23960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
93.6
323.0
1015
187
L57.0
ICD-10 Finland
Actinic keratosis
12.4
323.0
1227
1871
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.2
285.3
802
1560
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.4
238.7
883
2347
TQW99
NOMESCO Finland
Other minor procedure on skin
9.3
237.0
536
720
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
44.0
233.7
291
75
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
220.0
215.3
220
11
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
69.8
213.5
245
39
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
60.3
212.0
249
46
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
13.3
201.4
369
323
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
53.3
196.7
236
49
ZXC50
NOMESCO Finland
Cryotherapy
10.8
185.1
377
407
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
15.1
140.6
241
176
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.6
124.8
397
814
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
49.7
119.5
145
31
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
8.7
113.9
259
329
ZXC15
NOMESCO Finland
Use of photodynamic technique
12.9
103.9
190
159
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
49.1
96.3
117
25
S18
ICPC
Laceration/cut
2.4
87.8
1313
8107
ZXC20
NOMESCO Finland
Use of chemical agents
8.2
87.7
206
273
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
159.3
87.7
92
6
D06BB10
ATC
imiquimod; topical
5.4
81.8
265
542
L82
ICD-10 Finland
Seborrhoeic keratosis
2.9
79.6
599
2504
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.4
78.5
431
1445
D03.5
ICD-10 Finland
Melanoma in situ of trunk
33.8
64.9
85
26
XQ848
NOMESCO Finland
Dermatological photography
6.5
64.9
177
290
Z2221
NOMESCO Finland
Medical doctor
2.2
63.2
824
4536
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
22.4
50.7
74
34
A98
ICPC
Health maint/preventive medicine
2.9
48.1
2234
19787
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
41.7
45.8
57
14
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
4.4
45.3
174
421
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
44.3
261
898
ZQZ00
NOMESCO Finland
Treatment of several skin areas
12.1
43.4
80
68
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
63.8
43.3
50
8
SPAT1153
SPAT
Removal of sutures
1.9
43.3
937
6092
ZXE00
NOMESCO Finland
One hour or less
1.8
40.1
1017
6926
TQW80
NOMESCO Finland
Local dermatologic skincare
5.1
38.3
126
259
127
Kela drug reimbursment
Transplant complication
8.4
38.2
86
106
R4110
NOMESCO Finland
Physiotherapy
1.9
37.9
726
4466
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
4.1
36.4
149
382
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.3
36.2
141
345
S21
ICPC
Skin texture symptom/complaint
2.2
35.8
394
1930
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
35.7
1022
7147
S29
ICPC
Skin symptom/complaint other
2.1
35.0
495
2698
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.4
33.5
125
294
Z3231
NOMESCO Finland
Registered nurse
1.8
32.8
740
4769
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
172.3
32.8
34
*
L04AA06
ATC
mycophenolic acid; systemic
6.9
32.0
81
120
XQ845
NOMESCO Finland
Dermatoscopy
6.1
30.6
85
143
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
30.6
940
6622
Z94.0
ICD-10 Finland
Kidney transplant status
8.9
29.7
64
74
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
32.1
29.1
38
12
WX002
NOMESCO Finland
Sedation and analgesia
1.8
28.6
566
3463
WX110
NOMESCO Finland
Local anesthesy
1.6
28.3
1468
11812
E0000UV
ATC
NA
1.7
27.7
906
6442
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
11.6
27.4
51
45
D06BX02
ATC
ingenol mebutate; topical
5.1
27.3
88
178
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.9
26.9
113
297
QAE99
SPAT
NA
9.5
26.2
54
58
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.9
25.8
55
63
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
12.0
25.2
46
39
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.4
25.1
47
42
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
6.4
24.9
66
105
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
24.7
432
2519
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.2
23.8
18
1049
Z3226
NOMESCO Finland
Physiotherapist
1.8
23.5
481
2952
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
22.6
182
755
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
45.4
22.4
27
6
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
22.1
557
3633
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
0.0
21.9
*
574
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
11.0
21.6
41
38
L04AD01
ATC
ciclosporin; systemic
5.4
21.0
64
122
S82
ICPC
Naevus/mole
1.9
19.8
309
1719
8720/2-C44.5
ICD-O-3
Melanoma in situ of skin of trunk
+∞
19.8
19
*
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
19.8
19
*
S08
ICPC
Skin colour change
2.5
19.3
161
681
J01DB01
ATC
cefalexin; oral
1.6
19.0
1827
16138
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
18.8
1041
8162
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
6.3
18.5
49
79
D04
ICD-10 Finland
Carcinoma in situ of skin
44.3
18.2
22
5
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.6
17.9
82
234
D22
ICD-10 Finland
Melanocytic naevi
3.2
17.6
96
313
A02BC02
ATC
pantoprazole; systemic
1.5
17.4
1518
12973
ZXA00
NOMESCO Finland
Right side
1.5
17.2
709
5186
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
16.7
16
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
16.5
885
6831
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
4.8
16.4
54
114
N02BE01
ATC
paracetamol; systemic, rectal
1.6
16.4
2009
18333
L04AA01
ATC
[U] ciclosporin; systemic
4.4
16.2
58
133
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
16.2
482
3252
B07.9
ICD-10 Finland
Verruca simplex
3.2
16.0
84
268
D07AB08
ATC
desonide; topical
1.9
16.0
247
1368
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
15.8
610
4378
ZXA05
NOMESCO Finland
Left side
1.5
15.8
667
4885
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
6.4
15.8
41
65
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
3.9
15.6
64
167
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.1
15.4
30
30
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
6.1
14.8
40
67
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
14.8
449
3037
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
14.8
489
3378
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.3
14.7
74
229
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
21.2
14.6
21
10
L17
ICPC
Foot/toe symptom/complaint
1.5
14.6
596
4323
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.0
14.6
46
93
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
14.5
1181
9797
TQW40
SPAT
NA
2.8
14.3
92
334
A02BC01
ATC
omeprazole; systemic
1.5
14.1
681
5111
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
14.0
312
1939
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
13.9
1330
11316
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
13.7
1090
8968
XW000
NOMESCO Finland
Bone marrow biopsy
2.3
13.7
122
535
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.3
13.6
69
215
A12AA04
ATC
calcium carbonate; oral
3.7
13.6
58
158
M79.6
ICD-10 Finland
Pain in limb
1.4
13.6
783
6076
J01CA04
ATC
amoxicillin; systemic
1.4
13.5
1692
15067
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
13.4
435
2986
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
13.3
156
775
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
13.2
1541
13512
A11CC03
ATC
alfacalcidol; systemic
3.0
13.1
75
253
Z2446
NOMESCO Finland
Social worker
2.1
13.0
141
678
TK800
NOMESCO Finland
Hemodialysis
3.2
13.0
66
207
Z71.8
ICD-10 Finland
Other specified counselling
1.5
13.0
469
3297
R23.4
ICD-10 Finland
Changes in skin texture
4.9
12.5
40
83
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
12.4
642
4858
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.7
12.4
41
88
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
12.3
156
801
WX320
NOMESCO Finland
Spinalanesthesy
1.5
12.3
545
4000
L13
ICPC
Hip symptom/complaint
1.5
11.9
401
2769
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.6
11.7
362
2448
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.1
11.6
124
593
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.2
11.6
123
586
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
11.5
1005
8316
L04AX01
ATC
azathioprine; systemic
2.4
11.4
97
417
WXQ99
NOMESCO Finland
Other light therapy
15.1
11.3
18
12
137
Kela drug reimbursment
Uraemia requiring dialysis
4.9
11.3
36
75
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
11.2
231
1402
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
11.2
467
3375
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
11.2
811
6496
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
11.2
655
5057
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
11.0
709
5566
B03XA02
ATC
darbepoetin alfa; parenteral
3.2
11.0
57
183
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
10.9
99
441
H02AB06
ATC
prednisolone; systemic
1.3
10.9
1033
8635
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.5
10.9
31
57
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
4.9
10.8
34
70
D07AC01
ATC
betamethasone; topical
1.4
10.8
725
5725
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
21.5
10.7
15
7
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
10.6
736
5845
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
10.6
119
585
ZXA10
NOMESCO Finland
Bilateral
1.5
10.5
467
3419
J01MA02
ATC
ciprofloxacin; systemic
1.3
10.4
917
7557
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
10.4
108
511
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
12.1
10.3
18
15
J05AB11
ATC
valaciclovir; oral
1.6
10.3
280
1835
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
10.2
323
2195
B01AB04
ATC
dalteparin; parenteral
2.0
10.2
131
679
R06AE07
ATC
cetirizine; oral
1.4
10.1
814
6608
B01AB05
ATC
enoxaparin; parenteral
1.4
10.1
724
5772
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
8.5
10.0
21
25
J01FA10
ATC
azithromycin; systemic
1.3
10.0
1024
8624
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
9.9
590
4554
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
9.9
440
3217
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.3
9.9
87
383
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.8
9.9
174
1007
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
12.2
9.8
17
14
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
9.8
652
5123
H02AB04
ATC
methylprednisolone; systemic
1.5
9.6
316
2167
R05
ICD-10 Finland
Cough
1.5
9.6
415
3013
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.4
9.6
45
135
QAA25
SPAT
NA
10.1
9.5
18
18
S16
ICPC
Bruise/contusion
2.3
9.4
86
384
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
9.4
103
497
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.4
9.4
77
325
8742/2-C44.3
ICD-O-3
Lentigo maligna of skin of other and unspecified parts of face
100.4
9.4
10
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
9.4
937
7833
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
9.4
322
2226
ZXC10
NOMESCO Finland
Use of laser
2.7
9.4
60
222
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
9.4
956
8020
C07AB07
ATC
bisoprolol; oral
1.3
9.3
1235
10757
Z02.4
ICD-10 Finland
Examination for driving licence
1.4
9.2
622
4893
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
0.0
9.1
*
259
L28
ICPC
Limited function/disability (L)
1.4
9.1
425
3129
R06AX27
ATC
desloratadine; oral
1.4
9.1
405
2956
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
11.5
9.1
16
14
WW200
NOMESCO Finland
Immunization
2.6
9.0
63
246
ZXD20
NOMESCO Finland
Day surgery
1.5
9.0
277
1869
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
6.5
8.9
22
34
C08CA01
ATC
amlodipine; oral
1.3
8.9
929
7798
KMAK
NOMESCO Finland
NA
1.3
8.9
921
7724
J05AB01
ATC
aciclovir; systemic
1.4
8.9
424
3140
S26
ICPC
Fear of cancer of skin
3.5
8.9
40
117
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.3
8.8
42
128
UJF32
NOMESCO Finland
Coloscopy
1.4
8.8
621
4914
R04.0
ICD-10 Finland
Epistaxis
1.7
8.8
188
1153
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.8
778
6378
H02AB07
ATC
prednisone; oral
1.5
8.7
314
2195
D03.30
ICD-10 Finland
Melanoma in situ on the lip
50.2
8.7
10
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.7
8.6
168
1002
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
8.6
957
8097
R50.9
ICD-10 Finland
Fever, unspecified
1.5
8.6
290
1999
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
8.6
477
3625
Z01.2
ICD-10 Finland
Dental examination
1.3
8.6
705
5712
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
8.5
1002
8536
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.8
8.5
34
90
U13
ICPC
Bladder symptom/complaint other
2.2
8.5
83
385
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.5
663
5327
B05DA
ATC
Isotonic solutions
4.7
8.4
27
58
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.4
708
5752
SPAT1325
SPAT
Vaccination
1.3
8.4
865
7237
XKD00
NOMESCO Finland
Uroflowmetry
1.4
8.4
407
3020
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
8.4
581
4582
Z01.7
ICD-10 Finland
Laboratory examination
1.6
8.3
229
1501
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
8.3
174
1062
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
3.7
8.3
34
92
M04AA01
ATC
allopurinol; systemic
1.5
8.2
341
2452
3AC01
NOMESCO Finland
NA
4.0
8.2
31
78
DAB00
NOMESCO Finland
Excision of lesion of auricle
3.3
8.2
39
119
R60.0
ICD-10 Finland
Localized oedema
1.5
8.2
280
1931
ZX120
NOMESCO Finland
Intravenous
1.6
8.2
214
1389
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
2.9
8.1
48
170
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
8.1
555
4361
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
8.1
775
6412
M01AH05
ATC
etoricoxib; oral
1.3
8.0
1097
9511
5AB14
NOMESCO Finland
NA
22.1
8.0
11
5
M01AX05
ATC
glucosamine; oral
1.4
8.0
535
4191
K02.1
ICD-10 Finland
Caries of dentine
1.3
8.0
974
8316
L03
ICPC
Low back symptom/complaint
1.4
8.0
482
3710
B35.1
ICD-10 Finland
Tinea unguium
1.9
8.0
119
652
G04CA02
ATC
tamsulosin; oral
1.3
7.9
576
4569
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
7.9
310
2201
R4120
NOMESCO Finland
Occupational therapy
1.8
7.9
130
737
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.8
934
7945
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
7.8
207
1345
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
7.8
321
2303
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
7.0
7.8
18
26
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
7.7
198
1275
E000001
ATC
NA
1.4
7.7
387
2886
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
7.6
844
7103
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
7.6
172
1076
H81
ICPC
Excessive ear wax
1.4
7.6
409
3086
ZZR00
NOMESCO Finland
Flap of skin
2.2
7.6
73
335
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.2
7.6
71
324
J45
ICD-10 Finland
Asthma
1.6
7.6
181
1149
J02AC01
ATC
fluconazole; systemic
1.3
7.5
679
5556
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
7.5
395
2968
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
7.1
7.5
17
24
SPAT1336
SPAT
Request for examination
2.0
7.5
93
477
D02AE01
ATC
carbamide; topical
1.8
7.5
135
789
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
7.5
878
7447
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
7.4
919
7837
R01AD09
ATC
mometasone; nasal
1.3
7.4
776
6485
D03.8
ICD-10 Finland
Melanoma in situ of other sites
+∞
7.3
7
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
9.4
7.3
14
15
V03AE02
ATC
sevelamer; oral
5.8
7.2
19
33
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
7.2
111
619
ZXD05
NOMESCO Finland
Urgent procedure
1.3
7.2
632
5150
D03.2
ICD-10 Finland
Melanoma in situ of ear and external auricular canal
30.1
7.1
9
*
ZX197
NOMESCO Finland
NA
30.1
7.1
9
*
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
20.1
7.1
10
5
C44.92
ICD-10 Finland
Unspecified localization of spinocellular carcinoma of the skin
20.1
7.1
10
5
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.7
7.1
46
173
ZZA00
NOMESCO Finland
Split skin graft
2.1
7.0
77
377
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.0
67
308
M25.5
ICD-10 Finland
Pain in joint
1.3
7.0
498
3925
C03CA01
ATC
furosemide; systemic
1.3
7.0
833
7053
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.0
322
2359
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.4
7.0
57
245
M54.5
ICD-10 Finland
Low back pain
1.3
7.0
600
4869
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.0
645
5287
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
6.9
132
785
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.8
6.9
41
147
C08CA13
ATC
lercanidipine; oral
1.4
6.9
327
2411
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.4
6.8
373
2819
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
5.7
6.7
18
32
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
6.7
356
2673
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.9
6.7
88
465
VALMI
NOMESCO Finland
NA
1.4
6.7
401
3080
J01MA12
ATC
levofloxacin; systemic
1.4
6.7
414
3198
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
6.6
101
562
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
6.6
136
829
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
5.9
6.6
17
29
A02BC05
ATC
esomeprazole; systemic
1.3
6.6
840
7167
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
6.6
111
637
M10.9
ICD-10 Finland
Gout, unspecified
1.6
6.6
161
1028
R06.0
ICD-10 Finland
Dyspnoea
1.3
6.5
568
4607
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
6.5
438
3421
S02.51
ICD-10 Finland
Fracture of tooth, open
1.6
6.5
167
1080
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.5
349
2631
R01AD12
ATC
fluticasone furoate; nasal
1.3
6.5
420
3261
B03XA01
ATC
erythropoietin; parenteral
3.3
6.5
30
92
N05AX08
ATC
risperidone; systemic
0.5
6.4
63
1147
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
6.4
405
3138
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
6.3
70
346
QBE99
SPAT
NA
4.4
6.3
21
48
-44
ICPC
Preventive immunization/medic
1.5
6.3
211
1450
D07AA02
ATC
hydrocortisone; topical
1.5
6.3
232
1625
R53
ICD-10 Finland
Malaise and fatigue
1.3
6.3
454
3581
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
6.3
192
1294
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
11.0
6.3
11
10
N18.0
ICD-10 Finland
End-stage renal disease
2.9
6.3
36
125
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
6.3
169
1107
212
Kela drug reimbursment
Gout
2.2
6.3
57
259
8742/2-C44.5
ICD-O-3
Lentigo maligna of skin of trunk
+∞
6.3
6
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
6.2
39
811
D02AX
ATC
Other emollients and protectives
2.1
6.2
64
306
R03AC02
ATC
salbutamol; inhalant
1.2
6.2
1002
8769
L85.80
ICD-10 Finland
Hudhorn
4.3
6.2
21
49
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
6.2
156
1002
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
6.2
632
5234
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
5.0
6.2
18
36
N18.8
ICD-10 Finland
Other chronic renal failure
2.0
6.2
73
371
R83
ICPC
Respiratory infection other
1.4
6.2
275
2003
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
6.3
6.2
15
24
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.1
474
3776
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
1.9
6.1
81
428
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
6.1
414
3236
RS221
NOMESCO Finland
NA
3.1
6.1
31
102
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
3.5
6.1
26
75
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.1
738
6245
-1
NOMESCO Finland
NA
1.3
6.1
545
4438
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.5
6.1
10
8
Z49.2
ICD-10 Finland
Other dialysis
3.9
6.1
23
60
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
6.1
313
2341
R03DC03
ATC
montelukast; oral
1.4
6.1
267
1941
R05
ICPC
Cough
1.3
6.1
428
3370
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.7
6.0
117
702

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
2113
9267
6.11
307.65
2.9
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
758
3117
2.96
128.73
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
388
1056
4.10
126.77
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1435
9994
1.89
58.26
13.5
10.3
e9/l
0.0
0.0
1.05
1166
8113
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2479
21028
2.48
55.18
22.2
16.7
ml/min/173m2
69.3
72.2
9.66
2127
17444
(3018095) Leukocytes [#/volume] in Urine
1320
9059
1.86
55.08
5.5
3.9
e6/l
100.9
124.7
0.61
975
6627
(3001604) Monocytes [#/volume] in Blood
1582
11500
1.86
54.74
7.6
5.5
e9/l
0.6
0.6
0.04
1330
9759
(3006315) Basophils [#/volume] in Blood
1588
11562
1.86
54.62
7.6
5.5
e9/l
0.0
0.0
0.58
1337
9837
(3002385) Erythrocyte distribution width [Ratio]
2185
17698
2.04
53.62
28.3
21.4
%
14.0
13.9
2.04
2143
17254
(3019198) Lymphocytes [#/volume] in Blood
1601
11759
1.84
52.76
7.7
5.6
e9/l
2.0
1.9
0.45
1363
10168
(3030467) Casts [#/volume] in Urine by Automated count
1110
7288
1.86
52.67
4.7
3.3
e6/l
0.5
0.5
0.01
874
5611
(3022096) Basophils/100 leukocytes in Blood
1473
10569
1.82
52.19
8.2
5.8
%
0.6
0.7
0.82
1364
9763
(3023103) Potassium [Moles/volume] in Serum or Plasma
2677
23754
3.52
51.72
27.2
21.1
mmol/l
4.0
4.0
0.77
2619
23059
(3006504) Eosinophils/100 leukocytes in Blood
1500
10852
1.82
51.42
8.3
5.8
%
2.8
2.8
0.30
1383
10011
(3013115) Eosinophils [#/volume] in Blood
1614
11941
1.82
51.33
7.9
5.7
e9/l
0.2
0.2
0.80
1380
10302
(3010813) Leukocytes [#/volume] in Blood
2711
24287
4.03
50.64
33.4
25.8
e9/l
6.9
6.9
0.02
2622
23418
(3007461) Platelets [#/volume] in Blood
2710
24277
4.01
50.52
33.4
25.8
e9/l
235.1
242.3
6.56
2627
23523
(3019069) Monocytes/100 leukocytes in Blood
1501
10899
1.81
50.46
8.6
6.1
%
9.0
9.0
0.43
1394
10077
(3024731) MCV [Entitic volume]
2710
24281
4.00
50.43
33.3
25.7
fl
92.3
91.8
7.71
2663
23789
(3035941) MCH [Entitic mass]
2710
24282
4.00
50.40
33.3
25.7
pg
30.5
30.4
2.45
2663
23789
(3026361) Erythrocytes [#/volume] in Blood
2710
24283
4.00
50.38
33.4
25.8
e12/l
4.3
4.4
2.32
2613
23425
(3019550) Sodium [Moles/volume] in Serum or Plasma
2670
23714
3.38
50.30
26.7
20.9
mmol/l
139.6
139.6
0.06
2614
23061
(3000963) Hemoglobin [Mass/volume] in Blood
2710
24287
4.00
50.28
33.6
25.9
g/l
131.3
132.1
1.89
2666
23807
(3002582) Erythrocytes [#/volume] in Urine
1176
7951
1.82
50.05
4.8
3.4
e6/l
44.7
84.8
2.56
935
6205
(3018010) Neutrophils/100 leukocytes in Blood
1496
10900
1.79
49.25
8.0
5.8
%
58.7
58.7
0.07
1384
10077
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2661
23636
3.24
49.16
14.3
11.4
u/l
23.8
24.3
0.74
2554
22552
(42870588) Differential panel, method unspecified - Blood
1200
8205
1.81
48.86
7.6
5.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1512
11080
1.79
48.53
8.4
6.0
%
26.0
26.0
0.02
1398
10185
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2572
22484
2.64
48.38
23.2
17.5
mg/l
25.8
26.7
0.71
2145
18454
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1329
9419
1.78
47.47
4.9
3.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
62
76
8.32
47.10
32.1
26.1
ug/l
99.8
119.4
1.39
53
62
(36304419) Bacteria [Presence] in Urine
1047
7015
1.78
44.56
4.7
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2540
22271
2.42
43.97
5.8
5.4
mmol/l
2.5
2.6
8.26
2311
19896
(3013650) Neutrophils [#/volume] in Blood by Automated count
1745
13549
1.76
43.76
10.9
8.7
e9/l
4.2
4.3
0.74
1499
11755
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
707
4222
1.90
43.57
3.9
3.1
e6/l
1.8
2.5
1.50
404
2366
(3033658) Prothrombin time (PT) actual/Normal
939
6184
1.78
41.77
5.1
4.0
%
83.3
84.7
0.81
921
6025
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1721
13416
1.73
41.46
8.6
6.7
mmol/l
1.2
1.2
0.96
1455
11235
(3026250) Tacrolimus [Mass/volume] in Blood
51
59
8.78
40.55
35.8
30.4
ug/l
6.3
6.9
1.29
45
51
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2220
18688
1.88
40.43
9.7
7.6
u/l
81.8
80.8
0.31
2068
17430
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
729
4528
1.82
39.01
3.7
2.9
e6/l
1.0
1.3
1.16
425
2649
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2465
21620
2.12
38.15
5.0
4.8
mmol/l
4.4
4.5
6.01
2252
19413
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2445
21394
2.08
37.87
5.0
4.7
mmol/l
1.5
1.5
0.01
2216
19049
(3018418) pH of Serum or Plasma
1129
7995
1.69
37.70
5.8
4.0
ph
7.4
7.4
0.16
220
1492
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1292
9490
1.67
37.42
3.6
2.8
ug/l
142.6
149.5
0.54
1179
8534
(3031040) Bacteria [#/volume] in Urine by Automated count
2003
16522
1.73
36.93
6.5
5.3
e6/l
3601.3
2324.5
0.29
31
272
(3037467) Urinalysis macro (dipstick) panel - Urine
2015
16677
1.73
36.37
6.2
4.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2080
17374
1.75
36.25
5.4
4.3
mm/h
14.8
14.7
0.09
1905
15817
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1565
12170
1.64
35.46
7.5
5.8
mmol/l
1.2
1.2
0.32
1428
10896
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2370
20650
1.93
35.13
5.4
5.0
mu/l
2.1
2.1
0.01
2141
18391
(3024561) Albumin [Mass/volume] in Serum or Plasma
1491
11483
1.63
34.88
6.0
4.6
g/l
34.4
34.6
0.42
1360
10565
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2420
21250
1.98
34.80
7.1
6.6
mmol/mol
40.3
41.0
3.84
2217
19212
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2489
22074
2.09
34.79
5.6
5.2
mmol/l
6.0
6.1
1.01
2228
19535
(3009542) Hematocrit [Volume Fraction] of Blood
2236
19210
1.79
33.65
25.6
19.2
%
38.8
38.2
2.74
1495
11666
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1472
11405
1.61
32.77
2.3
2.1
pmol/l
95.1
93.8
0.43
734
5775
(3004789) Transferrin [Mass/volume] in Serum or Plasma
632
3943
1.78
32.49
3.3
2.5
g/l
2.2
2.3
1.07
592
3625
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
604
3720
1.79
32.44
3.5
2.6
%
21.7
21.6
0.05
539
3121
(3000850) Epithelial cells [#/volume] in Urine
840
5679
1.68
32.28
3.7
2.7
e6/l
4.3
5.4
2.20
734
4982
(3026493) Urate [Moles/volume] in Serum or Plasma
930
6457
1.66
32.25
3.9
2.9
umol/l
5080.6
7015.0
0.56
784
5444
(40758558) Short blood count panel - Blood
865
5929
1.66
31.35
8.0
6.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1212
9038
1.60
31.12
3.8
3.3
mmol/l
2.4
2.4
0.23
1022
7661
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2356
20709
1.84
30.93
4.5
4.2
mmol/l
1.3
1.3
0.27
2111
18232
(3000494) Fungus identified in Specimen by Culture
466
2732
1.85
29.14
1.6
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
535
3271
1.78
29.12
4.6
4.0
u/l
255.5
246.0
0.56
505
3060
(3026782) Osmolality of Urine
789
5365
1.65
29.10
4.0
2.9
mosm/kgh2o
544.2
544.7
0.02
690
4543
(40761511) CBC panel - Blood by Automated count
2528
22847
2.03
28.91
20.7
16.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
975
7007
1.60
28.61
2.6
2.3
mg/l
3.1
3.1
0.05
835
5901
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
779
5319
1.64
28.09
3.3
3.1
mmol/l
2.5
2.5
0.21
657
4646
(3022948) Iron [Moles/volume] in Serum or Plasma
653
4266
1.69
27.91
3.4
2.5
umol/l
12.0
12.1
0.06
618
3923
(3044889) 12 lead EKG panel
1960
16563
1.60
27.90
5.0
4.4
—
—
—
0
0
(4035726)
393
2223
1.89
27.39
1.4
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
552
3473
1.73
26.98
2.8
2.4
%
1.7
1.8
3.45
496
3032
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
17
14.23
26.22
4.9
6.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
389
2257
1.84
24.89
2.7
2.3
u/l
31.7
39.7
2.08
329
1906
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1280
10002
1.51
24.71
2.4
2.2
nmol/l
83.0
79.8
3.74
1124
8671
(3000991) Gas panel - Venous blood
390
2284
1.82
24.17
7.0
7.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
116
419
2.84
23.45
10.2
4.9
iu/ml
985.3
4669.3
0.45
23
57
(3013826) Glucose [Moles/volume] in Serum or Plasma
1774
14926
1.51
23.33
5.4
4.7
mmol/l
6.8
6.9
1.34
1696
14042
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1344
10692
1.49
23.28
2.5
2.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1979
17068
1.54
22.91
4.2
4.0
pmol/l
15.0
15.1
1.45
1770
15080
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1591
13121
1.49
22.86
7.1
6.1
umol/l
12.4
12.1
0.48
1504
12396
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
96
329
2.99
21.36
4.1
2.4
u/ml
91.4
1522.3
—
5
26
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1161
9096
1.47
20.99
3.6
3.2
ng/l
2560.7
1736.5
2.50
1019
7915
(3012095) Magnesium [Moles/volume] in Serum or Plasma
615
4214
1.59
20.93
3.8
2.9
mmol/l
0.8
0.8
0.42
558
3894
(3021960) Folate [Moles/volume] in Serum or Plasma
917
6874
1.50
20.61
1.7
1.6
nmol/l
20.9
20.3
0.60
782
5758
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
815
5980
1.51
20.25
1.6
1.6
mmol/l
1.3
1.3
0.30
681
4920
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
133
556
2.46
20.11
4.7
2.6
mg/l
2.0
1.7
2.15
121
489
(3023368) Bacteria identified in Blood by Culture
1026
7895
1.47
20.10
5.5
4.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
748
5401
1.52
20.01
4.5
4.1
ng/l
394.0
498.6
0.20
658
4689
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
425
2701
1.68
19.47
3.3
2.6
umol/l
10.3
9.5
0.21
379
2360
(3003458) Phosphate [Moles/volume] in Serum or Plasma
523
3516
1.60
19.11
9.5
5.2
mmol/l
1.0
1.0
0.30
489
3223
(3007164) IgA [Mass/volume] in Serum or Plasma
548
3729
1.58
19.01
1.8
1.5
g/l
2.8
2.7
0.28
304
2081
(3007853) Bacteria identified in Skin by Aerobe culture
446
2893
1.64
18.83
2.0
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
395
2486
1.68
18.73
12.0
6.4
mmol/l
11.6
11.1
0.58
381
2345
(3032080) INR in Blood by Coagulation assay
1382
11356
1.43
18.54
13.1
11.1
inr
1.3
1.4
0.86
378
3048
(3018677) aPTT in Platelet poor plasma by Coagulation assay
596
4180
1.54
17.97
2.2
1.9
s
30.4
30.0
0.73
582
4029
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
238
1308
1.90
17.86
4.3
3.4
mmol/l
24.0
24.2
0.23
222
1170
(3020630) Protein [Mass/volume] in Serum or Plasma
391
2497
1.66
17.47
2.5
2.6
g/l
65.1
66.2
1.90
347
2239
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
353
2200
1.69
17.30
4.8
3.6
ng/l
114.5
95.8
2.18
292
1843
(3003338) MCHC [Mass/volume]
1995
17637
1.45
17.09
30.8
23.5
g/l
330.1
330.9
4.47
1976
17460
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1559
13194
1.41
17.08
3.3
3.2
u/l
56.5
55.8
0.09
1413
11899
(3035350) Ketones [Presence] in Urine by Test strip
1393
11581
1.40
16.84
4.7
4.2
estimate
0.0
0.0
0.00
298
2134
(3021601) Nitrite [Presence] in Urine by Test strip
1393
11595
1.40
16.64
6.6
5.6
estimate
0.0
0.0
0.00
308
2126
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1084
8671
1.41
16.23
5.7
5.6
ug/l
3.1
4.0
0.59
947
7645
(3014111) Lactate [Moles/volume] in Serum or Plasma
380
2458
1.63
16.07
5.6
5.9
mmol/l
1.3
1.4
1.76
364
2366
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
669
4909
1.48
15.99
3.6
3.3
ug/l
0.8
0.8
0.25
489
3521
(3044640) Blood type and Crossmatch panel - Blood
1006
7961
1.41
15.95
3.0
2.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
250
1445
1.80
15.95
1.7
1.7
g/l
1.5
1.5
0.32
214
1231
(3009261) Glucose [Presence] in Urine by Test strip
1403
11764
1.38
15.66
4.7
4.2
estimate
0.0
0.0
0.80
304
2096
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
652
4778
1.47
15.64
2.1
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
483
3328
1.54
15.57
1.9
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
399
2635
1.60
15.46
3.0
2.4
e9/l
65.5
68.1
0.81
287
2012
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
132
618
2.19
15.41
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
132
618
2.19
15.41
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
522
3671
1.52
15.28
2.1
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
32
64
5.05
15.25
1.8
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1093
8841
1.39
14.97
4.2
3.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
477
3306
1.53
14.91
2.0
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
396
2632
1.59
14.91
1.4
1.3
titre
603.6
549.7
0.19
78
610
(3002032) Base excess in Venous blood by calculation
404
2705
1.58
14.73
4.5
3.4
mmol/l
1.8
2.0
0.61
345
2174
(3021447) Carbon dioxide [Partial pressure] in Venous blood
405
2722
1.57
14.51
4.5
3.4
kpa
5.9
5.8
0.42
395
2636
(3005719) IgG [Mass/volume] in Serum or Plasma
270
1650
1.70
14.15
3.7
2.7
g/l
10.3
10.7
0.60
249
1485
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
792
6112
1.41
14.14
2.8
2.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
124
603
2.10
13.18
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
278
1748
1.65
13.06
1.8
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
242
1481
1.69
12.60
6.9
7.9
mmol/l
24.3
24.4
0.13
227
1376
(3002179) Metamyelocytes/100 leukocytes in Blood
289
1858
1.62
12.42
5.1
3.8
%
0.5
0.5
0.10
72
442
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
178
1002
1.83
12.38
2.0
2.5
g/l
1.1
1.2
0.11
153
847
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
289
1866
1.61
12.20
1.8
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
298
1946
1.59
11.99
5.5
4.0
%
0.1
0.1
0.05
98
580
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
307
2026
1.58
11.81
1.6
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1320
11277
1.32
11.63
4.8
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
867
6969
1.35
11.61
3.5
3.1
u/l
34.4
36.7
0.55
803
6564
(3052851) Hemolysis interference index of Serum or Plasma
149
810
1.89
11.58
4.1
3.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
157
868
1.86
11.58
1.8
2.4
g/l
0.1
0.0
0.27
141
788
(3017181) Myelocytes/100 leukocytes in Blood
310
2060
1.57
11.57
5.5
4.0
%
0.7
0.9
0.70
104
634
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
337
2283
1.54
11.54
6.4
3.6
mmol/l
1.2
1.2
0.30
294
1976
(3042733) HLA Ab [Presence] in Serum
21
37
5.71
11.47
5.4
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
315
2111
1.55
11.32
2.5
2.4
—
—
—
0
0
(3000492) Spirometry study
270
1761
1.59
10.91
1.9
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
283
1867
1.57
10.89
1.7
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
147
816
1.85
10.72
1.8
2.4
g/l
0.0
0.0
0.00
133
741
(3028026) IgM [Mass/volume] in Serum or Plasma
212
1310
1.67
10.64
2.2
1.8
g/l
1.0
1.5
6.74
190
1163
(3024891) Influenza virus A+B Ag [Presence] in Specimen
102
501
2.07
10.62
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
457
3352
1.43
10.48
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
185
1108
1.72
10.43
1.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
309
2101
1.53
10.38
1.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
392
2799
1.47
10.37
4.2
3.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
33
94
3.54
10.04
1.3
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
584
4503
1.37
9.97
6.3
4.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
272
1814
1.55
9.97
5.5
4.0
%
0.1
0.3
0.52
81
486
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
159
928
1.76
9.84
1.8
2.3
g/l
36.8
37.3
0.37
139
780
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
193
1190
1.67
9.78
1.9
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
193
1191
1.67
9.75
1.9
2.4
g/l
7.5
7.5
0.06
154
868
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
142
804
1.81
9.74
1.8
2.4
g/l
0.0
0.0
0.00
130
740
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
852
6980
1.32
9.65
4.8
4.8
%
22.7
22.0
0.64
420
3732
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
551
4230
1.38
9.63
1.3
1.2
u/ml
2.1
1.6
0.17
108
1036
(3022145) Colonoscopy Study observation
355
2522
1.47
9.61
1.4
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
192
1188
1.66
9.60
1.9
2.4
g/l
3.8
3.8
0.09
146
837
(3024354) Oxygen [Partial pressure] in Venous blood
324
2261
1.49
9.59
3.5
2.8
kpa
4.5
4.4
0.28
316
2182
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
132
736
1.83
9.52
1.8
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
717
5750
1.33
9.39
4.1
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
186
1150
1.66
9.33
2.9
2.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
69
306
2.29
9.30
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
70
313
2.27
9.26
3.9
3.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
66
288
2.32
9.24
1.8
1.3
u/ml
116.9
128.1
—
10
56
(3036489) Thrombin time
139
796
1.78
9.19
2.0
1.9
s
21.9
21.9
0.02
127
719
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
74
341
2.20
9.11
1.8
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
178
1099
1.66
8.99
2.0
2.4
g/l
3.2
3.1
0.12
147
856
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
181
1123
1.65
8.97
1.9
2.4
g/l
9.6
10.4
2.11
159
933
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
91
459
2.02
8.87
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
107
575
1.89
8.69
2.2
2.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
72
337
2.17
8.55
1.9
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
88
445
2.01
8.53
3.7
3.5
%
62.0
58.8
1.37
88
445
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
962
8116
1.28
8.48
2.3
2.2
u/l
192.3
222.3
0.62
896
7558
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
631
5051
1.32
8.23
1.8
1.7
mg/l
1.6
1.5
0.40
488
3932
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
171
1071
1.64
8.18
3.1
2.8
u/ml
0.3
0.3
1.16
95
618
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
34
5.02
8.14
1.2
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
110
611
1.83
8.08
2.8
2.2
g/l
3.6
3.7
0.25
102
576
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
87
448
1.97
8.03
2.3
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
945
8007
1.27
7.91
3.8
3.1
mmol/l
6.5
6.9
3.18
798
6569
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
63
290
2.20
7.83
1.3
1.1
u/ml
282.0
316.5
0.42
40
168
(3001964) Herpes simplex virus Ag [Presence] in Specimen
23
61
3.79
7.79
2.5
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
73
359
2.06
7.67
1.9
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
38
140
2.74
7.60
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
63
294
2.17
7.58
2.0
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
99
546
1.84
7.46
2.6
2.4
%
198.1
206.3
0.43
93
517
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
46
189
2.46
7.41
2.3
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
72
357
2.04
7.41
2.3
2.1
pg
32.8
32.5
0.22
72
352
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
37
4.62
7.40
1.2
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
976
8373
1.25
7.19
4.8
3.9
mg/mmol
11.3
9.0
0.77
651
5230
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
159
1016
1.60
7.05
3.7
3.2
mg/l
41.1
68.0
1.00
121
847
(3048929) Epstein Barr virus Ab [Presence] in Serum
77
399
1.96
7.03
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
103
587
1.78
7.00
2.2
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
159
1018
1.60
6.99
3.6
3.2
mg/l
86.9
111.6
0.16
121
844
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
155
987
1.60
6.97
3.5
3.2
ratio
1.5
1.7
0.28
11
77
(3016750) Collection duration of Urine
38
147
2.61
6.95
2.9
2.0
min
495.9
491.6
0.11
30
105
(3012516) Albumin [Mass/volume] in Urine
926
7924
1.25
6.91
3.9
3.2
mg/l
215.3
320.9
0.49
628
4992
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
106
612
1.76
6.90
2.0
1.4
g/l
1.1
1.2
1.21
100
582
(3003327) Ova and parasites identified in Stool by Light microscopy
101
575
1.78
6.89
1.8
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
437
3403
1.34
6.80
1.4
1.3
iu/ml
45.9
38.5
0.36
124
1065
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
34
126
2.72
6.76
1.7
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
106
616
1.75
6.75
2.1
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
103
594
1.76
6.74
2.3
2.1
%
91.0
88.3
0.58
94
566
(21494434) Karyotype in Bone marrow
56
262
2.16
6.73
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
145
2.57
6.61
2.5
2.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
709
5916
1.27
6.51
1.9
1.8
nmol/l
1192.2
1173.7
0.19
532
4374
(40768441) Liver Pathology biopsy report
38
153
2.50
6.43
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
273
1990
1.41
6.40
6.0
4.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
82
449
1.85
6.38
1.4
1.5
g/l
31.0
31.2
0.04
71
409
(3004775) Volume in Urine collected for unspecified duration
48
217
2.23
6.29
2.9
2.2
ml
682.1
620.4
0.53
35
134
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
173
2.39
6.29
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
77
418
1.87
6.16
1.9
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
100
588
1.73
6.14
2.2
1.5
g/l
0.2
0.2
1.36
92
561
(3036481) Cortisol [Moles/volume] in Serum or Plasma
282
2089
1.39
6.02
2.2
2.1
nmol/l
362.5
378.1
0.56
265
1875
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
143
927
1.57
6.01
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
52
248
2.12
5.99
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
361
2783
1.34
5.99
3.2
3.1
ng/l
267.4
237.4
0.52
335
2548
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
62
317
1.98
5.94
1.3
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
66
346
1.93
5.88
1.5
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
714
6024
1.25
5.88
3.7
3.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
296
2223
1.37
5.82
2.2
1.9
ug/g
152.5
150.9
0.02
230
1705
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
107
654
1.66
5.72
1.5
1.3
—
16.3
—
0
12
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
115
719
1.62
5.63
1.6
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
156
1049
1.52
5.58
1.9
1.5
u/ml
8.8
21.4
—
5
25
(3025130) Human papilloma virus identified in Specimen
32
128
2.52
5.53
1.7
1.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
67
362
1.87
5.48
1.4
1.4
e6/l
27182.8
76463.3
1.28
29
215
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
386
3049
1.31
5.39
3.7
3.9
ug/l
28.3
21.6
0.19
303
2522
(3051651) Icteric interference index of Serum or Plasma
36
155
2.34
5.33
4.2
3.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
896
7810
1.22
5.32
2.8
2.5
u/l
69.3
58.0
1.45
799
7145
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
118
754
1.59
5.31
1.5
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
25
90
2.79
5.30
2.3
2.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
30
4.35
5.29
13.4
17.4
mmol/l
8.6
5.5
0.51
13
30
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
408
3256
1.30
5.28
1.3
1.2
u/ml
13.3
15.1
0.16
128
1116
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
26
4.63
5.26
4.0
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
506
4154
1.27
5.22
39.2
29.6
inr
1.5
1.5
0.47
72
539
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
36
157
2.31
5.19
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
117
754
1.58
5.09
1.3
1.5
ug/g
296.8
266.0
0.94
63
447
(21494814) CD8 cells/100 lymphocytes in Specimen
22
76
2.91
5.03
1.1
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
90
550
1.66
4.87
3.1
2.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
70
399
1.77
4.86
1.5
1.4
e6/l
1188.0
2048.2
1.45
39
293
(3006184) Hemoglobin [Mass/volume] in Capillary blood
103
652
1.60
4.85
2.5
2.2
g/l
122.4
126.7
0.82
74
466
(3042111) Morphology [Interpretation] in Bone marrow Narrative
85
514
1.67
4.79
1.8
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
654
5575
1.23
4.77
1.4
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
63
3.03
4.67
1.3
1.9
—
—
—
0
0
(3010421) pH of Blood
112
731
1.55
4.64
5.2
4.5
ph
7.4
7.4
0.12
93
612
(3017446) Testosterone [Moles/volume] in Serum or Plasma
185
1336
1.41
4.63
2.5
2.1
nmol/l
13.3
11.9
1.01
154
1137
(3051611) Lipemic interference index of Serum or Plasma
56
303
1.87
4.62
4.1
3.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
203
1491
1.39
4.60
2.5
2.5
—
—
—
0
0
(4010399)
229
1722
1.36
4.50
1.6
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
112
737
1.54
4.49
3.4
3.1
mmol/l
24.8
25.2
0.42
97
639
(40760888) Immunoglobulin light chains.free panel - Serum
115
762
1.53
4.47
4.3
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
57
314
1.83
4.45
1.5
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
60
336
1.80
4.45
1.5
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
97
621
1.58
4.39
5.2
4.8
mmol/l
2.4
2.8
0.61
66
429
(3036525) Urea [Moles/time] in 24 hour Urine
9
12
7.52
4.35
4.9
4.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
204
1519
1.37
4.27
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
106
699
1.54
4.23
2.1
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
72
432
1.68
4.22
7.9
2.8
—
—
—
0
0
(3024471) HLA-A [Type]
14
41
3.43
4.18
1.2
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
99
645
1.55
4.17
3.2
2.8
kpa
8.0
7.8
0.75
90
595
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
34
160
2.14
4.15
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
34
160
2.14
4.15
1.4
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
134
2.25
4.15
1.3
2.0
%
20.8
15.1
—
8
50
(3027801) Oxygen [Partial pressure] in Arterial blood
402
3299
1.25
4.13
6.0
6.2
kpa
12.1
11.8
0.49
379
3127
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
24
97
2.49
4.13
1.8
1.5
g/l
0.9
1.0
0.27
24
97
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
402
3300
1.25
4.12
6.0
6.2
kpa
5.0
5.1
1.68
380
3127
(3041096) Erythrocytes [Presence] in Urine by Automated
683
5925
1.20
4.10
4.9
3.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
76
469
1.64
4.02
1.3
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
143
1013
1.43
4.02
2.1
2.2
ug/l
299.2
733.8
1.35
136
957
(3003396) Base excess in Arterial blood by calculation
401
3304
1.25
3.98
5.9
6.2
mmol/l
0.6
1.2
2.22
320
2535
(40767503) Oxygen content in Capillary blood by calculation
94
615
1.55
3.91
3.1
2.5
%
15.6
15.8
0.20
55
311
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
294
2339
1.29
3.90
1.4
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
63
373
1.70
3.90
1.7
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
150
1082
1.41
3.83
2.1
2.0
—
—
—
0
0
(1002224) Polysomnography panel
81
516
1.59
3.79
1.1
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
39
3.34
3.76
1.3
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
85
549
1.57
3.75
1.3
1.1
titre
81.0
90.9
—
10
34
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
18
66
2.74
3.75
1.6
1.7
ug/l
0.3
0.4
—
10
39
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
52
295
1.78
3.75
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
31
147
2.12
3.74
1.4
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
31
147
2.12
3.74
1.4
1.4
—
—
—
0
0
(44790049)
48
266
1.82
3.73
2.1
1.5
—
—
—
0
0
(44806118)
48
266
1.82
3.73
2.1
1.5
—
—
—
0
0
(44790048)
48
266
1.82
3.73
2.1
1.5
—
—
—
0
0
(44790047)
48
266
1.82
3.73
2.1
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
36
181
2.00
3.73
2.0
2.0
e9/l
1.0
1.0
0.26
26
105
(3000475) Leukocytes [#/volume] in Synovial fluid
98
657
1.51
3.67
1.6
1.6
e6/l
11605.1
16561.5
0.79
67
474
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
272
3376
0.78
3.54
9.9
8.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
44
242
1.83
3.52
1.1
1.2
u/l
51.7
58.9
0.35
30
164
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
173
1.98
3.43
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
69
434
1.60
3.43
1.4
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
22
94
2.35
3.41
3.8
1.8
ug/l
43.5
58.6
0.82
22
89
(3037121) Protein [Mass/volume] in Urine
130
936
1.41
3.39
3.5
2.9
g/l
0.3
0.3
0.04
62
353
(40768795) Lymph node Pathology biopsy report
41
224
1.84
3.37
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
101
2.29
3.36
1.1
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
215
1684
1.30
3.25
1.5
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
305
2498
1.25
3.21
2.3
2.0
g/l
0.2
0.2
0.95
282
2311
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
48
280
1.73
3.19
1.4
1.3
pmol/l
208.6
261.4
1.00
38
208
(3025941) Bacteria identified in Stool by Culture
157
1179
1.35
3.19
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
130
2.09
3.18
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
226
1792
1.28
3.12
3.5
3.1
g/l
125.3
126.9
0.51
219
1746
(3009871) Measles virus Ab [Titer] in Serum
12
39
3.09
3.09
1.7
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
87
592
1.48
3.08
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
89
611
1.47
3.02
1.7
1.6
iu/ml
0.0
9.5
0.59
22
144
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
140
2.01
3.00
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
140
2.01
3.00
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
140
2.01
3.00
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
19
81
2.35
2.98
3.2
1.3
—
—
—
0
0
(4094501)
85
582
1.47
2.94
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
102
724
1.42
2.92
1.3
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
105
750
1.42
2.91
1.3
1.2
u/ml
0.2
0.6
—
6
69
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
142
1.98
2.90
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
142
1.98
2.90
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
142
1.98
2.90
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
84
2.27
2.77
3.1
2.7
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
6
8.35
2.75
3.0
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
146
1.93
2.70
1.5
1.8
u/l
1.3
2118.8
—
7
49
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
276
2282
1.23
2.69
1.4
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
70
470
1.50
2.69
5.6
3.8
%
1.0
1.5
0.60
50
355
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
242
1978
1.24
2.63
2.8
2.8
ml/min/173m2
57.0
59.7
0.56
123
897
(3011985) Renin [Units/volume] in Plasma
48
297
1.63
2.62
1.4
1.3
mu/l
52.8
54.2
0.03
42
254
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
58
376
1.55
2.62
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
89
632
1.42
2.58
5.1
3.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
320
2699
1.21
2.57
6.6
6.9
g/l
117.2
119.7
1.33
308
2599
(3036603) Volume of Urine
28
149
1.89
2.56
1.6
1.4
ml
1789.9
1626.9
—
8
39
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
76
525
1.46
2.55
1.4
1.2
u/ml
1.9
4.5
—
8
49
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
223
1.71
2.54
1.6
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
47
293
1.61
2.51
1.4
1.2
u/l
10.1
11.8
0.40
35
228
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
130
988
1.33
2.50
2.8
2.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
39
232
1.69
2.49
1.7
1.6
u/ml
14.3
22.5
—
10
45
(3014765) Yersinia sp identified in Stool by Organism specific culture
95
688
1.39
2.48
1.2
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
302
1.60
2.47
1.5
1.5
g/l
0.7
0.8
0.30
33
231
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
21
3.82
2.46
2.1
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
27
144
1.88
2.46
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
52
335
1.56
2.43
1.6
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
95
691
1.39
2.42
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
40
242
1.66
2.41
1.1
1.2
u/ml
4.2
4.4
—
10
76
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1123
10448
1.12
2.40
4.7
4.2
ng/l
401.2
60.3
0.46
867
8143
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
60
401
1.51
2.39
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
39
235
1.67
2.39
1.2
1.2
u/ml
2.1
6.0
2.14
15
111
(3048879) Bone marrow aspiration report
20
97
2.07
2.37
1.5
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
76
535
1.43
2.34
1.4
1.2
u/ml
4.0
6.5
0.56
12
87
(3013512) EKG study
860
7884
1.13
2.34
4.8
4.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
93
680
1.38
2.31
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
87
632
1.39
2.26
2.5
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
660
5965
1.14
2.24
1.8
1.7
pmol/l
452.4
20138306.2
3.54
518
4787
(3027456) Digoxin [Moles/volume] in Serum or Plasma
109
823
1.34
2.23
3.3
3.2
nmol/l
0.8
0.8
0.50
82
627
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
39
240
1.63
2.22
2.7
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
9
5.56
2.21
1.8
5.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
48
2.51
2.18
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
64
444
1.45
2.15
1.4
1.2
u/ml
23.0
4.9
—
5
33
(3042631) Mycobacterium sp identified in Specimen
59
403
1.47
2.15
2.7
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
184
1496
1.25
2.14
8.2
8.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
343
2964
1.18
2.13
6.3
6.5
%
95.7
95.3
0.55
331
2843
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
47
307
1.54
2.11
1.1
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
25
3.21
2.09
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24
131
1.84
2.08
2.3
1.8
e6/l
536.8
672.8
—
9
59
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
10
5.01
2.07
2.2
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
115
889
1.31
2.02
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
26
147
1.78
2.02
2.2
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
287
1.54
2.00
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
35
217
1.62
1.97
1.2
1.1
u/ml
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
151
1214
1.26
1.96
1.3
1.3
au/ml
71.0
58.4
—
6
51
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
51
2.36
1.95
1.2
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
12
51
2.36
1.95
1.0
1.9
ug/l
1.3
2.1
—
6
30
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
59
413
1.44
1.92
1.5
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
39
2.57
1.92
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
150
1.74
1.90
1.7
1.5
u/l
18.1
6.7
0.55
15
69
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
131
1040
1.27
1.90
3.7
3.1
u/ml
3649.5
4954.2
0.15
118
873
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
121
1.82
1.88
1.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
14
65
2.16
1.88
1.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
160
1.69
1.81
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
39
254
1.54
1.81
2.7
1.5
—
—
—
0
0
(4133840)
9
35
2.58
1.80
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
88
670
1.32
1.76
3.3
2.2
ug/min
89.9
92.6
0.04
59
391
(3043410) Blood group antigens tested for on Red Blood Cells
14
67
2.09
1.76
2.4
2.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
147
1.71
1.74
1.4
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
34
217
1.57
1.73
1.3
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
48
2.30
1.70
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
89
1.92
1.70
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
472
5225
0.88
1.69
5.5
4.7
kg/l
1.0
1.0
0.24
73
838
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
41
275
1.50
1.69
1.2
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
45
308
1.47
1.68
1.5
1.5
%
70.0
62.7
0.71
28
204
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
479
0.64
1.68
1.5
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
45
309
1.46
1.66
7.5
4.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
90
1.89
1.65
1.1
1.3
ug/l
417.4
371.5
—
10
49
(3013139) Helicobacter pylori Ag [Presence] in Stool
175
1462
1.21
1.63
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
37
245
1.52
1.62
1.2
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
27
167
1.62
1.58
1.1
1.1
%
90.3
93.7
0.33
22
156
(3017354) Segmented neutrophils/100 leukocytes in Blood
43
296
1.46
1.58
5.7
3.7
%
54.6
58.4
0.30
22
185
(3003181) Sodium [Moles/volume] in Urine
73
551
1.33
1.58
1.2
1.3
mmol/l
62.7
61.1
0.13
61
443
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
8
173
0.46
1.58
1.1
1.0
ng/l
398.8
330.2
—
8
105
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
8
175
0.46
1.57
1.1
1.0
ng/l
56.4
47.4
—
8
105
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
8
175
0.46
1.57
1.1
1.0
ng/l
686.0
622.1
—
8
103
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
21
122
1.73
1.54
1.6
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
14
71
1.98
1.53
3.1
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
33
2.43
1.53
1.8
1.3
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
15
3.34
1.52
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
206
1761
1.18
1.51
4.5
3.6
ph
7.4
7.4
1.13
41
212
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
21
123
1.71
1.50
1.6
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
108
1.76
1.50
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
108
1.76
1.50
1.1
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
163
1366
1.21
1.49
2.4
2.5
au/ml
37.8
26.9
—
7
45
(3029075) Extractable nuclear Ab panel - Serum
12
58
2.07
1.49
1.1
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
208
1783
1.18
1.49
4.5
3.6
kpa
5.1
5.2
0.12
192
1633
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
2.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
2.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
2.6
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
65
2.00
1.48
1.2
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
16
87
1.84
1.45
4.2
2.3
u/ml
157469.7
32002.7
—
6
15
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
145
1210
1.21
1.40
3.0
3.2
pmol/l
4.3
4.4
0.79
128
1037
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
63
475
1.33
1.40
1.2
1.2
u/l
28.1
40.0
0.67
54
415
(3033799) Differential panel - Peritoneal fluid
15
81
1.86
1.40
1.8
2.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
111
1.72
1.39
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
222
1.49
1.38
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
67
1.94
1.38
1.2
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
174
1480
1.19
1.38
4.7
3.3
mmol/l
25.1
25.2
0.18
169
1434
(4034850)
58
767
0.75
1.37
12.2
12.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
6
23
2.61
1.36
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
129
1069
1.22
1.35
1.3
1.3
u/ml
476.7
221.3
0.68
121
973
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
183
1.54
1.34
1.4
1.3
g/l
0.5
0.4
0.31
16
132
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
183
1.54
1.34
1.4
1.3
g/l
6.5
7.2
0.35
17
132
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
183
1.54
1.34
1.4
1.3
g/l
2.3
2.8
0.94
17
132
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
47
2.13
1.33
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
113
1.69
1.31
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
24
2.50
1.30
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
63
482
1.31
1.29
1.2
1.2
—
268.3
—
0
12
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
301
2685
1.14
1.29
2.4
2.5
ug/l
5.9
6.7
0.46
264
2278
(21494890) Protein electrophoresis panel - 24 hour Urine
43
310
1.39
1.28
2.3
2.0
—
—
—
0
0
(4062490)
28
187
1.50
1.23
1.3
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
25
163
1.54
1.23
1.1
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
19
2.63
1.21
1.8
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
197
1715
1.16
1.20
1.6
1.7
%
1.5
1.6
0.25
158
1411
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
71
559
1.28
1.19
1.4
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
38
2.11
1.18
1.4
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
27
181
1.50
1.18
2.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
684
6407
1.09
1.17
5.5
4.6
estimate
0.0
0.0
0.69
294
2030
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
133
1.58
1.17
3.1
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
133
1.58
1.17
3.1
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
133
1.58
1.17
3.1
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
133
1.58
1.17
3.1
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
73
579
1.27
1.16
1.3
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
50
2.00
1.16
1.6
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
102
1.67
1.16
1.1
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
194
1696
1.15
1.13
4.5
3.6
mmol/l
1.4
2.1
1.74
152
1248
(3013727) Leukocytes other/100 leukocytes in Blood
16
95
1.69
1.13
4.8
4.1
%
41.8
55.9
1.47
16
90
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
292
3238
0.89
1.11
5.0
4.9
%
35.1
33.7
1.40
209
2050
(4268621)
25
168
1.49
1.09
2.0
2.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
41
1.95
1.08
1.5
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
161
1.49
1.06
3.7
3.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
105
1.62
1.06
3.7
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
21
137
1.54
1.05
2.0
1.5
umol/l
15.2
14.6
0.15
21
126
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
33
2.12
1.05
10.9
4.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
305
1.35
1.05
1.1
1.3
iu/l
28.6
33.1
0.41
34
257
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
924
8796
1.08
1.05
5.4
4.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
38
280
1.36
1.04
2.9
3.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
72
887
0.81
1.03
4.8
5.6
mmol/l
1.3
1.3
0.21
61
780
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
110
927
1.19
1.03
1.9
1.8
u/l
37.7
39.0
0.19
93
787
(3035880) pH of Pleural fluid
27
188
1.44
1.01
1.3
1.3
—
—
—
0
0
(4306422)
31
222
1.40
1.00
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
128
1098
1.17
0.98
1.2
1.2
iu/ml
119.3
145.5
0.39
48
391
(3018133) Calcium [Moles/volume] in Urine
0
29
0.00
0.97
0.0
1.8
—
3.3
—
0
23
(3018572) Chloride [Moles/volume] in Blood
50
638
0.78
0.97
5.7
6.3
mmol/l
104.5
105.2
0.62
43
572
(3039000) Anion gap in Blood
50
638
0.78
0.97
5.7
6.3
mmol/l
11.6
11.0
0.55
43
572
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
25
173
1.45
0.97
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
50
1.80
0.96
2.4
2.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
54
1.85
0.96
1.7
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
27
2.22
0.93
1.3
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
164
1857
0.88
0.91
5.8
6.2
mmol/l
24.0
24.5
1.05
151
1727
(3006270) Folate [Moles/volume] in Blood
33
244
1.36
0.91
1.1
1.2
nmol/l
336.0
330.9
0.04
24
197
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
313
0.70
0.89
1.2
1.1
iu/ml
1.0
70.2
—
6
58
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
31
228
1.36
0.88
1.1
1.1
—
13.2
—
0
9
(3036071) Salmonella sp Ab [Titer] in Serum
8
42
1.91
0.88
1.1
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
14
87
1.61
0.87
1.3
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
103
1.56
0.87
3.8
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
103
1.56
0.87
3.8
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
128
1.49
0.85
1.7
2.6
%
39.4
36.5
—
9
47
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
44
1.82
0.85
1.9
1.6
ng/l
149.4
139.2
—
8
44
(44816559) Phosphatidylethanol [Mass/volume] in Blood
39
300
1.30
0.84
1.4
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
102
873
1.17
0.84
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
43
336
1.28
0.83
1.5
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
225
2038
1.11
0.81
1.7
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
13
81
1.61
0.81
1.1
1.1
ratio
1.1
1.1
—
6
21
(3017732) Neutrophils [#/volume] in Blood
169
1506
1.13
0.81
2.7
3.4
e9/l
3.6
4.2
3.52
115
1063
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
268
1.31
0.79
1.2
1.3
nmol/l
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
61
501
1.22
0.79
2.8
1.6
mg/l
2.6
4.0
0.59
50
385
(3051387) C reactive protein [Mass/volume] in Capillary blood
49
607
0.80
0.78
4.2
3.7
mg/l
26.2
28.4
0.17
35
382
(3024263) Appearance of Synovial fluid
22
156
1.41
0.78
1.5
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(4198724)
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
81
685
1.19
0.78
1.7
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
82
1.59
0.78
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
21
148
1.42
0.77
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
28
208
1.35
0.77
1.4
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
107
1.50
0.76
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
45
359
1.26
0.76
1.1
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
53
1.70
0.75
1.2
2.8
%
218.6
203.3
—
9
46
(3035637) Corticotropin [Mass/volume] in Plasma
33
253
1.31
0.75
1.5
1.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
54
1.67
0.74
1.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
75
634
1.19
0.73
1.7
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
22
300
0.73
0.73
3.5
4.2
umol/l
306.6
342.2
0.75
22
258
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
25
2.00
0.72
1.4
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
84
1.55
0.71
1.8
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
57
1.58
0.71
1.1
1.1
miu/ml
2134.6
1674.5
—
9
57
(3000034) Microalbumin [Mass/volume] in Urine
28
212
1.32
0.70
3.5
3.1
mg/l
89.9
23.6
0.64
21
161
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
9
58
1.55
0.69
1.7
2.2
%
35.2
28.1
—
9
50
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
17
118
1.44
0.69
2.8
2.0
e9/l
0.3
0.2
0.24
17
105
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
117
0.60
0.68
1.3
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
34
267
1.28
0.66
1.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
43
1.63
0.66
1.3
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
28
1.79
0.66
2.8
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
50
412
1.22
0.65
3.2
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
78
1.54
0.65
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
64
542
1.19
0.64
1.3
1.4
—
—
—
0
0
(4281824)
32
251
1.28
0.64
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
423
1.21
0.63
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
208
1.30
0.62
1.1
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
33
262
1.26
0.61
1.5
1.3
e6/l
231676.3
147220.8
0.23
26
179
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
48
398
1.21
0.60
1.4
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
51
1.57
0.60
2.4
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
45
371
1.22
0.60
3.3
2.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.9
—
17.4
—
0
22
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
166
1.33
0.58
1.0
1.1
u/ml
0.4
1.9
1.02
12
63
(4146454)
25
321
0.78
0.58
3.1
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
71
613
1.16
0.58
2.5
2.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
50
419
1.20
0.57
3.2
2.4
mmol/l
106.9
105.3
1.89
50
414
(3041354) Potassium [Moles/volume] in Venous blood
50
419
1.20
0.57
3.2
2.4
mmol/l
4.1
4.1
0.12
50
414
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
54
1.48
0.57
2.1
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
54
1.48
0.57
1.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
73
1.51
0.56
1.5
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
37
1.62
0.55
4.0
2.7
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
1.2
1.3
nmol/l
5.6
5.4
—
6
31
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
99
1.42
0.54
1.0
1.0
u/ml
0.7
1.4
—
7
34
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
222
1.26
0.53
1.1
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
61
1.48
0.53
3.8
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
74
1.49
0.53
1.2
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
39
1.54
0.53
1.7
2.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
332
1.21
0.52
1.9
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
79
895
0.88
0.51
3.9
3.6
mmol/l
3.8
3.9
0.68
73
822
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
40
1.50
0.51
1.5
2.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
135
1.34
0.51
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
52
444
1.17
0.50
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
70
798
0.87
0.50
1.5
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
16
118
1.36
0.50
1.3
1.3
nmol/l
1.0
1.0
0.01
11
89
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
225
1.25
0.49
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
84
1.43
0.49
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
65
567
1.15
0.49
2.2
1.9
mg/l
12.7
12.2
0.14
60
510
(3002523) Influenza virus A Ag [Presence] in Specimen
18
136
1.33
0.49
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
39
326
1.20
0.48
1.9
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
111
0.63
0.48
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
172
1.28
0.48
2.8
2.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
48
1.46
0.46
1.3
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
39
328
1.19
0.46
1.9
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
120
1.34
0.46
1.4
1.5
nmol/l
0.2
0.3
1.09
11
96
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
17
129
1.32
0.45
1.1
1.2
mmol/l
13.3
11.7
—
7
42
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
51
440
1.16
0.45
3.1
1.4
nmol/l
0.8
0.8
0.12
44
354
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
85
0.59
0.45
1.4
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
147
1.29
0.45
2.4
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
103
1.36
0.45
1.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
65
572
1.14
0.45
1.6
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
7
51
1.37
0.44
2.1
5.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
39
330
1.18
0.44
1.9
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
51
442
1.16
0.43
1.9
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
18
140
1.29
0.42
2.9
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
58
1.38
0.41
1.3
1.3
ug/l
7.6
9.2
—
8
58
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
15
0.00
0.41
0.0
1.5
—
22.3
—
0
7
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(4212803)
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
18
141
1.28
0.40
4.7
3.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.5
umol/l
84.2
41.4
—
5
35
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
137
1269
1.08
0.39
5.0
3.7
—
—
—
0
0
(4024509)
34
288
1.18
0.39
1.7
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
38
326
1.17
0.38
1.9
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
247
0.81
0.38
2.0
2.1
u/field
1.3
1.9
—
8
76
(3006442) Creatine [Moles/volume] in Serum or Plasma
11
147
0.75
0.37
1.7
1.6
—
72.9
—
0
7
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
38
327
1.16
0.37
1.9
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
134
1.27
0.37
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
134
1.27
0.37
1.2
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
217
2295
0.94
0.36
4.9
3.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
132
1226
1.08
0.36
2.7
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
201
0.79
0.35
1.1
1.1
—
2.2
—
0
5
(3050129) First trimester maternal screen panel - Serum or Plasma
5
80
0.62
0.35
2.0
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
126
0.71
0.35
8.3
6.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
123
1142
1.08
0.34
2.3
1.8
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
73
1.37
0.34
1.8
1.7
pmol/l
18.4
15.4
—
5
58
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
246
1.18
0.34
1.4
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
302
1.16
0.34
1.5
1.7
mu/l
325.6
301.6
0.26
30
271
(3014271) Vancomycin [Susceptibility]
23
191
1.21
0.33
2.8
3.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
86
0.70
0.33
1.2
1.4
%
38.8
23.1
—
6
70
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
100
1081
0.92
0.32
5.7
4.0
mmol/l
24.5
24.9
0.63
95
986
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
192
1.20
0.32
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
97
897
1.08
0.31
1.8
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
98
0.71
0.30
2.0
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
98
0.71
0.30
2.0
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
193
1.19
0.30
1.3
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
12
153
0.78
0.30
1.4
2.3
mmol/l
7.3
9.4
1.70
12
125
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
240
1.17
0.30
1.6
1.4
%
21.8
27.2
0.45
16
154
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
93
1.29
0.30
1.0
1.1
u/ml
1.5
2.8
—
5
34
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
132
1239
1.07
0.29
1.9
1.8
ug/l
1.9
2.5
0.26
115
1060
(3000330) Specific gravity of Urine by Test strip
157
1485
1.06
0.28
5.0
3.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
129
0.77
0.28
1.1
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
11
85
1.30
0.28
9.2
4.9
u/ml
40.0
73.3
—
5
16
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
47
422
1.12
0.27
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
121
0.74
0.27
1.2
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
65
1.23
0.27
4.4
2.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
36
405
0.89
0.26
3.9
3.8
u/ml
22.9
43.7
1.91
36
394
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
73
0.68
0.26
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
73
0.68
0.26
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
73
0.68
0.26
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
73
0.68
0.26
1.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
160
0.81
0.26
2.0
1.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
19
160
1.19
0.25
2.3
2.1
ug/min
78.8
94.6
—
6
34
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
74
1.22
0.25
10.9
1.9
ug/l
11.8
124.7
—
9
66
(4015189)
9
77
1.17
0.24
1.6
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
117
1239
0.94
0.24
4.4
4.7
%
0.8
0.9
0.29
109
1168
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
189
1.17
0.24
1.2
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
118
1249
0.94
0.24
4.5
4.7
%
1.5
1.5
0.04
111
1178
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
180
1.17
0.23
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
179
0.84
0.23
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
36
323
1.12
0.22
1.2
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758358) Immune stain study
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.1
—
4.9
—
0
7
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
10.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(44813793)
9
113
0.80
0.20
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
99
1.21
0.19
2.4
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
25
281
0.89
0.19
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
260
1.12
0.19
1.1
1.2
miu/ml
196.6
221.4
—
7
84
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
90
1.22
0.19
1.0
1.5
—
—
—
0
0
(3019225) pH of Specimen
293
2849
1.03
0.18
6.4
4.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
137
1.17
0.18
1.2
1.3
u/ml
0.4
1.5
—
6
71
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
60
1.17
0.17
2.4
2.6
—
—
—
0
0
(4211845)
16
138
1.16
0.17
2.6
4.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
18
157
1.15
0.17
1.1
1.2
mmol/l
1.9
2.1
1.46
18
145
(3027008) Opiates [Presence] in Urine
14
163
0.86
0.17
1.9
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
163
0.86
0.17
1.9
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
7
63
1.11
0.17
1.0
1.0
%
103.4
96.1
—
7
47
(3006462) Nitrate [Presence] in Urine
15
129
1.16
0.17
2.7
4.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
44
474
0.93
0.16
1.9
1.7
iu/l
3.5
4.4
0.43
18
154
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
39
360
1.08
0.16
1.2
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
172
0.87
0.15
11.8
16.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
76
0.79
0.15
1.2
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
78
0.77
0.15
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
60
565
1.06
0.15
1.7
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
79
1.14
0.15
1.6
2.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
36
332
1.09
0.15
3.8
6.2
mmol/l
6.4
7.5
2.53
29
275
(3000764) Benzodiazepines [Presence] in Urine
14
161
0.87
0.15
1.9
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
27
296
0.91
0.14
1.8
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
139
0.86
0.14
1.7
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
64
675
0.95
0.14
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
170
1752
0.97
0.14
3.1
3.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
107
0.84
0.13
1.1
1.2
nmol/l
102.9
140.6
—
9
107
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
221
1.09
0.11
1.2
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
165
0.91
0.08
1.1
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
6
56
1.07
0.08
1.0
1.2
—
104.6
—
0
11
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
63
0.79
0.08
1.2
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
37
389
0.95
0.08
2.1
2.2
mg/l
28.5
24.5
—
10
91
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
88
1.14
0.08
2.7
4.3
%
13.4
13.3
—
10
88
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
62
598
1.04
0.08
1.5
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
85
1.06
0.07
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
193
1961
0.98
0.07
3.7
4.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
13
118
1.10
0.07
1.5
1.6
—
10.0
—
0
5
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
118
1.10
0.07
1.2
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
88
1.02
0.07
1.7
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
285
0.95
0.06
1.9
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
152
0.92
0.06
1.8
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
203
0.94
0.06
1.2
1.2
mmol/l
8.5
7.7
0.45
13
137
(3023410) Appearance of Cerebral spinal fluid
21
198
1.06
0.05
1.3
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
44
453
0.97
0.04
1.4
1.4
e6/l
1015.2
798.9
0.11
36
375
(3020891) Body temperature
114
1156
0.99
0.03
4.6
4.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
44
452
0.97
0.03
1.2
1.3
e6/l
13.3
31.9
0.66
32
356
(3044290) Cell count panel - Cerebral spinal fluid
40
411
0.97
0.03
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
28
272
1.03
0.02
1.9
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
308
0.97
0.02
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
117
0.94
0.01
1.3
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
82
829
0.99
0.01
6.1
4.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
15
156
0.96
0.00
2.8
2.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
18
174
1.03
0.00
2.4
2.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
115
0.96
0.00
1.3
1.5
umol/l
9.6
15.6
—
5
65
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
155
1.03
0.00
2.8
1.9
—
—
—
0
0
(44806420)
11
109
1.01
0.00
2.0
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
129
1.01
0.00
1.8
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
164
0.98
0.00
2.7
2.5
—
—
—
0
0
(3019977) pH of Arterial blood
18
176
1.02
0.00
2.4
2.6
ph
7.4
7.4
—
9
59
(3020491) Glucose [Moles/volume] in Blood
18
178
1.01
0.00
1.3
2.8
mmol/l
7.1
7.0
0.10
12
118
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
11
107
1.03
0.00
1.6
1.6
nmol/l
15.1
16.1
0.17
11
94
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
143
0.98
0.00
1.1
1.1
u/ml
1.4
2.0
—
8
53
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
60
1.00
0.00
1.2
1.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
9
89
1.01
0.00
1.3
1.2
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3012989) Citrate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
2.1
—
0
8
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.5
—
0
5
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
15.1
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.6
—
0
9
(3052592) Norovirus Ag [Presence] in Stool
6
59
1.02
0.00
1.3
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
82
0.98
0.00
2.3
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
81
0.99
0.00
1.8
1.8
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
208.4
—
0
6
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
8
89
0.90
0.00
1.0
1.1
ng/l
—
392.5
—
0
21
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
4.5
—
0
8
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
8
83
0.96
0.00
1.6
1.9
u/l
43.9
77.6
—
8
77

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_SKIN – Carcinoma in situ of skin

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).